© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
All News
New Joint Commission Requirements Likely to Boost Maternal Patient Safety
July 07, 2020
The outlook for decreasing the maternal mortality rate in the country has recently improved as a result of a recent initiative by the Joint Commission, which has developed 13 new elements of performance (EOPs) to help evaluate hospitals.
Culture-building is a Business Imperative Amid COVID-19
July 07, 2020
Crisis tests a business's culture. It also is a good time to create or strengthen a culture.
Short 'Bursts' of Oral Corticosteroids Are Associated With GI Bleeds, Other Adverse Events
July 07, 2020
The risk of long-term use of oral corticosteroids are well known. This research shows that short "bursts" of one to two weeks also carry some risk of adverse events.
Stat, Applied XL: COVID-19 Trials Too Small to Give Clear Answers
July 06, 2020
Almost 40% of trials are designed to have fewer than 100 patients.
Boosting Molecular Testing in Patients with GIST Would Have Minimal Cost Impact, Study Finds
July 06, 2020
Researchers cost-impact model calculates the cost to be 15 centers PMPY.
Word From FDA, NIH on COVID-19 Vaccine: No Cutting Corners
July 05, 2020
FDA outlines what it will take to get a COVID-19 vaccine approved, while NIH offers its research strategy.
Could COVID-19 Winnow Out Low-Value Cancer Care?
July 02, 2020
Authors of JAMA Oncology opinion piece see priorities set in response to the pandemic as a chance to discourage low-value cancer care.
Survey: Rheumatologists Still Reluctant to Switch Patients to Biosimilars
July 02, 2020
Cardinal Health recently conducted a survey of more than 100 rheumatologists asking their feelings about biosimilars, and the findings revealed that the majority of them were familiar with and comfortable prescribing biosimilars.